All In Biotech

Drug Trial Radar · NCT01358760

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

Last checked: Nov 20, 2026Latest source record: Jun 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

450

Actual

Start

Jun 2011

Primary completion

Apr 2012

Study completion May 2012

Sponsor

Lead sponsor
EndoCeutics Inc.Industry
Sponsor type
Industry
First posted
May 24, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 40 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Phase III trial is to evaluate the efficacy of intravaginal dehydroepiandrosterone (DHEA) in postmenopausal women with vaginal atrophy.

Conditions

  • Vaginal Atrophy

Interventions

  • PlaceboDrug

    Placebo vaginal suppository

  • DHEADrug

    Vaginal suppository containing 0.25% (3.25 mg) DHEA

  • DHEADrug

    Vaginal suppository containing 0.5% (6.5 mg) DHEA

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 12 in Percentage of Parabasal Cells in the Maturation Index of the Vaginal SmearTime frame: Baseline and Week 12
  2. Change From Baseline to Week 12 in Percentage of Superficial Cells in the Maturation Index of the Vaginal SmearTime frame: Baseline and Week 12
  3. Change From Baseline to Week 12 in Vaginal pHTime frame: Baseline and Week 12
  4. Change From Baseline to Week 12 in Severity of the Most Bothersome Symptom of Vaginal DrynessTime frame: Baseline and Week 12

Locations

42 sites in 2 countries. Site status is shown where the registry gives one.

  • EndoCeutics site # 39

    Montgomery, Alabama

  • EndoCeutics site # 14

    Tucson, Arizona

  • EndoCeutics site # 65

    Little Rock, Arkansas

  • EndoCeutics site # 21

    Sacramento, California

  • EndoCeutics site # 30

    San Diego, California

  • EndoCeutics site # 36

    Denver, Colorado

  • EndoCeutics site # 52

    Denver, Colorado

  • EndoCeutics site # 66

    Danbury, Connecticut

  • EndoCeutics site # 42

    Milford, Connecticut

  • EndoCeutics site # 57

    West Hartford, Connecticut

  • EndoCeutics site # 61

    Newark, Delaware

  • EndoCeutics site # 26

    Jacksonville, Florida

  • EndoCeutics site # 60

    Lake Worth, Florida

  • EndoCeutics site # 54

    North Miami, Florida

  • EndoCeutics site # 56

    Pinellas Park, Florida

  • EndoCeutics site # 23

    Sandy Springs, Georgia

  • EndoCeutics site # 10

    Meridian, Idaho

  • EndoCeutics site # 55

    Wichita, Kansas

  • EndoCeutics site # 27

    Baltimore, Maryland

  • EndoCeutics site # 24

    Omaha, Nebraska

  • EndoCeutics site # 50

    Neptune City, New Jersey

  • EndoCeutics site # 33

    Beachwood, Ohio

  • EndoCeutics site # 05

    Cleveland, Ohio

  • EndoCeutics site # 47

    Cleveland, Ohio

  • EndoCeutics site # 15

    Columbus, Ohio

  • EndoCeutics site # 62

    Providence, Rhode Island

  • EndoCeutics site # 64

    Jackson, Tennessee

  • EndoCeutics site # 63

    Memphis, Tennessee

  • EndoCeutics site # 53

    San Antonio, Texas

  • EndoCeutics site # 51

    Sandy City, Utah

  • EndoCeutics site # 09

    West Jordan, Utah

  • EndoCeutics site # 03

    Norfolk, Virginia

  • EndoCeutics site # 13

    Calgary, Alberta, Canada

  • EndoCeutics site # 06

    Bathurst, New Brunswick, Canada

  • EndoCeutics site # 59

    Toronto, Ontario, Canada

  • EndoCeutics site # 04

    Drummondville, Quebec, Canada

  • EndoCeutics site # 12

    Montreal, Quebec, Canada

  • EndoCeutics site # 02

    Québec, Quebec, Canada

  • EndoCeutics site # 01

    Québec, Quebec, Canada

  • EndoCeutics site # 18

    Saint Romuald, Quebec, Canada

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.